Deferred Tax Assets, Valuation Allowance of Emmaus Life Sciences, Inc. from 30 Sep 2011 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Emmaus Life Sciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Sep 2011 to 31 Dec 2024.
  • Emmaus Life Sciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $38,838,000, a 9.5% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Emmaus Life Sciences, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $38,838,000 -$4,057,000 -9.5% 31 Dec 2024 10-K 14 Apr 2025 2024 FY
Q4 2023 $42,895,000 -$1,217,000 -2.8% 31 Dec 2023 10-K 14 Apr 2025 2024 FY
Q4 2022 $44,112,000 +$3,965,000 +9.9% 31 Dec 2022 10-K 03 Jul 2024 2023 FY
Q4 2021 $40,147,000 +$2,717,000 +7.3% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q4 2020 $37,430,000 -$589,000 -1.5% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q4 2019 $38,019,000 +$3,826,000 +11% 31 Dec 2019 10-K/A 10 Aug 2021 2020 FY
Q4 2018 $34,193,000 31 Dec 2018 10-K 25 Jan 2021 2019 FY
Q3 2018 $16,928,130 -$6,066,023 -26% 30 Sep 2018 10-K 11 Dec 2018 2018 FY
Q3 2017 $22,994,153 +$1,522,217 +7.1% 30 Sep 2017 10-K 11 Dec 2018 2018 FY
Q3 2016 $21,471,936 +$4,151,136 +24% 30 Sep 2016 10-K 29 Dec 2017 2017 FY
Q3 2015 $17,320,800 +$2,703,600 +18% 30 Sep 2015 10-K 22 Dec 2016 2016 FY
Q3 2014 $14,617,200 -$1,928,900 -12% 30 Sep 2014 10-K 05 Jan 2016 2015 FY
Q3 2013 $16,546,100 -$475,100 -2.8% 30 Sep 2013 10-K 29 Dec 2014 2014 FY
Q3 2012 $17,021,200 +$30,239,700 30 Sep 2012 10-K 23 Dec 2013 2013 FY
Q3 2011 $13,218,500 30 Sep 2011 10-K 15 Jan 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.